Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				FAQs: National Defense Authorization Act						Print
																Related Pages
										The National Defense Authorization Act for Fiscal Year 2002 (Pub. L. 107-107; Section 3151(b)) and the Ronald W. Reagan National Defense Authorization Act for Fiscal Year 2005 (Pub. L. 108-375; Section 3161) made several amendments to the Energy Employees Occupational Illness Compensation Program Act (EEOICPA).
To find answers to your questions about the National Defense Authorization Act, click any one of the questions listed below to view its answer.
National Defense Authorization Acts for 2002 and 2005What is the National Defense Authorization Act of 2002?
	The National Defense Authorization Act of 2002 (NDAA) (Pub. L. 107-107) is a federal law that was enacted to specify that fiscal year’s budget and expenditures of the United States Department of Defense. Section 3151 of the NDAA made several amendments to the Energy Employees Occupational Illness Compensation Program Act of 2000 (EEOICPA), as follows:
Revised the threshold standard for determining if a covered employee has contracted silicosis
Clarified inclusion of Atomic Weapon Employer (AWE) employees as members of the Special Exposure Cohort (SEC)
Clarified payment of attorney’s fees
Clarified who qualifies as survivors and their entitlement to compensation benefits not paid to the covered employee
Added a technical amendment dealing with certain covered leukemia
Clarified the effect of EEOICPA on pertinent tort actions filed both before and after the original EEOICPA date of enactment, and subsequent to the date of enactment of the NDAA amendments to EEOICPA
Required that NIOSH conduct a study on potential health effects of any residual contamination at certain facilities, with the cooperation of the Departments of Energy (DOE) and Labor (DOL), and report to Congress on the study’s resultsWhere can I find out more about the residual contamination study that NIOSH was required to conduct under the National Defense Authorization Act of 2002?
	Additional information on the residual contamination study can be found on the Residual Contamination Report FAQs page of our website.Where can I find a copy of the National Defense Authorization Act of 2002?
	A copy of the National Defense Authorization Act of 2002 can be found on The Act (EEOICPA) page of our website. You can also request a copy of the act by contacting NIOSH directly at 513-533-6800, toll-free at 1-877-222-7570, or sending an e-mail request to dcas@cdc.gov.What is the Ronald W. Reagan National Defense Authorization Act of 2005?
	The Ronald W. Reagan National Defense Authorization Act of 2005 (NDAA) (Pub. L. 108-375) is a federal law that was enacted to specify that fiscal year’s budget and expenditures of the United States Department of Defense. Section 3161 of the NDAA made several amendments to the Energy Employees Occupational Illness Compensation Program Act of 2000 (EEOICPA), as follows:
**Changes to Subtitle B of EEOICPA** 
The definition of a “covered employee” was expanded to include workers who were employed at atomic weapons employer (AWE) facilities during time periods when NIOSH determined that significant residual contamination existed outside of the period when weapons-related production occurred.
A radiation dose definition only applicable to the residual contamination periods.
A time limit of 180 days was established for NIOSH to provide a recommendation to the Advisory Board regarding qualified Special Exposure Cohort (SEC) petitions.
The time limit Congress has to either approve or deny a class to be added to SEC was reduced from 180 days to 30 days.
**Changes to Subtitle D of EEOICPA** 
Subtitle D of EEOICPA that was managed by the Department of Energy (DOE) was replaced by Subtitle E which is managed by the Department of Labor (DOL).
**Changes to Subtitle E of EEOICPA** 
Part E of EEOICPA was created in the place of Subtitle D.
This program provides federal compensation to covered employees based on the level of impairment and/or wage loss if they develop an occupational illness as a result of exposure to toxic substances at a DOE facility.
Medical benefits are also available to qualifying employees for treatment and care of the accepted occupational illness.
Certain survivors of deceased workers are also eligible to receive compensation.
Part E eligibility was added for uranium workers covered by section 5 of the Radiation Exposure Compensation Act managed by the Department of Justice.Additional information on Subtitle E of EEOICPA can be found on the DOL EEOICP Website.Where can I find a copy of the Ronald W. Reagan National Defense Authorization Act of 2005?
	A copy of the Ronald W. Reagan National Defense Authorization Act of 2005 can be found on The Act (EEOICPA) page of our website. You can also request a copy of the act by contacting NIOSH directly at 513-533-6800, toll-free at 1-877-222-7570, or sending an e-mail request to dcas@cdc.gov.
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue